Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention

Published:2018-01-16 Issue:3 Volume:137 Page:307-309
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

McEvoy John W.¹²³,Ibrahim Khalil²,Kickler Thomas S.⁴,Clarke William A.⁴,Hasan Rani K.²,Czarny Matthew J.²,Keramati Ali R.²,Goli Rakesh R.⁵,Gratton Travis P.⁵,Brinker Jeffrey A.²,Chacko Matthews²,Hwang Chao-Wei²,Johnston Peter V.²,Miller Julie M.²,Trost Jeffrey C.²,Herzog William R.²,Blumenthal Roger S.¹²,Thiemann David R.²,Resar Jon R.²,Schulman Steven P.²

Affiliation:

1. Ciccarone Center for the Prevention of Heart Disease (J.W.M., R.S.B.)

2. Division of Cardiology, Department of Medicine (J.W.M., K.I., R.K.H., M.J.C., A.R.K., J.A.B., M.C., C.-W.H., P.V.J., J.M.M., J.C.T., W.R.H., R.S.B., D.R.T., J.R.R., S.P.S.)

3. Johns Hopkins University School of Medicine, Baltimore, MD. Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.W.M.).

4. Department of Pathology (T.S.K., W.A.C.)

5. Department of Medicine (R.R.G., T.P.G.)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031678

Reference5 articles.

1. Sedation, Analgesia, and Anaesthesia Variability in Laboratory-Based Cardiac Procedures: An International Survey

2. The on- and off-target effects of morphine in acute coronary syndrome: A narrative review

3. Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: Design, rationale, and sample characteristics of the PACIFY randomized trial